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Abstract
Background: Osteoarthritis (OA) is a leading cause of pain and disability, which may be a source of productivity
losses. The objectives of this study were to describe the impact of OA, namely through pain and physical disability,
on early exit from work and to calculate its economic burden.
Methods: We analysed data from the national, cross-sectional, population-based EpiReumaPt study (Sep2011–Dec2013)
in which 10,661 individuals were randomly surveyed in order to capture all cases of rheumatic diseases. We used all
participants aged 50–64, near the official retirement age, who were clinically validated by experienced
rheumatologists (n = 1286), including OA cases. A national database was used to calculate productivity values by
gender, age and region, using the human capital approach. The impact of OA on the likelihood of early exit from work
and the population attributable fractions used to calculate due economic burden (indirect costs) were obtained at the
individual level by logistic regression. All results were based on weighted data.
Results: Almost one third of the Portuguese population aged 50–64 had OA (29.7%; men: 16.2% and women: 43.5%) and
more than half were out of paid work (51.8%). Only knee OA is associated with early exit from work (OR: 2.25;
95%CI: 1.42–3.59; p = 0.001), whereas other OA locations did not reach any statistical difference. Furthermore, we
observed an association between self-reported longstanding musculoskeletal pain (OR: 1.55; 95%CI: 1.07–2.23; p = 0.02)
and pain interference (OR: 1.35; 95%CI: 1.13–1.62; p = 0.001) with early exit from work. We also detected a clear
relationship between levels of disability, measured by the Health Assessment Questionnaire (HAQ), and the probability of
work withdrawal. The estimated annual cost of early exit from work attributable to OA was €656 million (€384 per capita;
€1294 per OA patient and €2095 per OA patient out-of-work).
Conclusions: In this study, we observed an association between OA and early exit from work, largely dependent on pain
and disability. This relationship translates into a meaningful economic burden amounting to approximately 0.4% of the
national Gross Domestic Product (GDP). The high prevalence and the impact of this disabling chronic disease highlight
the need to prioritize policies targeting early exit from work in OA.
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Background
Osteoarthritis (OA) is a degenerative joint disorder and
the most common form of arthritis in adults [1]. It is
characterized by pain and functional impairment, which
may lead to disability, including work restriction [2–4].
In many western countries the population is ageing
due to increasing longevity and falling birth rates [5].
Portugal, for instance, is amongst the oldest countries in
the world, and has one of the highest old-age depend-
ency ratios, further aggravated by the fact that currently
unemployment and overall premature work withdrawal
are still high [6].
Numerous factors, including health-related prob-
lems, may contribute to the high rate of exit from
the workforce that persists at a global level [7–11]. In
fact, several studies have already shown that ill-health
is a risk factor for early exit from work, including re-
tirement and unemployment [12, 13, 16]. A deeper
understanding of these factors is crucial to support
policies for increasing productivity and postponing
exit from work.
The growing prevalence of chronic disabling dis-
eases, such as OA, jeopardizes any effort to prolong
the working life of the labour force of modern soci-
eties. In spite of this, research about the effect of OA
on work participation and its economic burden is still
lacking [14, 15].
Thus, the objectives of this study were to describe
the impact of OA, namely through pain and physical
disability, on early exit from work and to calculate its
economic burden.
Methods
Sample
This study uses the first national, cross-sectional,
population-based study on rheumatic diseases in
Portugal – the EpiReumaPt study [16]. The method-
ology of EpiReumaPt has been detailed elsewhere
[17]. Briefly, EpiReumaPt (September 2011–Decem-
ber 2013) randomly selected a representative sample
of 10,661 adult subjects who self-reported several
data following a questionnaire applied by trained
staff. Rheumatologists then performed a standardized
physical examination and appropriate laboratory/im-
aging evaluation on those participants with rheum-
atic complaints/symptoms.
For the purposes of this analysis we used data from
EpiReumaPt participants aged between 50 and 64 years
old, near the official retirement age, who were clinically
evaluated by the rheumatologists (n = 1286).
Measures
We considered the presence of OA through clinical con-
firmation initially done by a rheumatologist and then
validated by a team of three experienced rheumatolo-
gists, in accordance with the American College of
Rheumatology (ACR) classification criteria, of at least
one type of OA: knee OA [18], hip OA [19], and hand
OA [20]. All those without any of these OA types were
considered to be non-OA.
The following self-reported measures were used:
major chronic diseases (rheumatic diseases, diabetes,
cardiovascular diseases including risk factors such as
hypertension and high cholesterol, allergy, pulmon-
ary disease, gastrointestinal disease, neurological dis-
ease, mental disease, and cancer); comorbidity score
(built as the sum of all aforementioned chronic
illnesses); body mass index (BMI, derived from self-
reported height and weight and categorized as
underweight: < 18.5m2/kg, normal: 18.5-25 m2/kg,
overweight: 25-30 m2/kg and obese: ≥30 m2/kg);
quality of life (using the final 0–100 score from the
SF-36 Health Survey [21, 22] and its eight items
separately, including the bodily pain; and the
European Quality of Life questionnaire with five
dimensions and three levels validated for Portugal,
EQ-5D index [23, 24]); longstanding musculoskeletal
pain (≥3 months); pain interference with function (i.e. pain
affecting labour and domestic activities based on the SF-
36 question: During the past 4 weeks, how much did pain
interfere with your normal work, including both work out-
side the home and housework?); functional capacity (0–3
score from the Health Assessment Questionnaire,
HAQ [25]); marital status; household monthly in-
come; and educational level (classified into three
major levels according to the highest degree com-
pleted: primary school or less, basic education be-
tween primary and secondary levels, and secondary
education or more, including university degrees).
Since the underlying etiological model of this re-
search, which connects OA with early exit from work,
comprises pain and disability as important intermedi-
ate steps, we analysed them in further detail by using
the abovementioned instruments.
Regarding the case definition for the main out-
come, individuals were asked directly about their
employment status and all those who did not report
any kind of paid work (part- or full-time), including
students, housekeepers or anyone without a regular
salary; as well as those in official early retirement or
disability pensions, were included in the early exit
from paid employment group. All those reporting
any form of regularly paid work were considered
employed. This definition was used elsewhere in
earlier research [1, 26].
A broader definition of early withdrawal from work
allows us to take into account the existence of different
pathways to early retirement. However, we also
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considered it relevant to separately analyse more specific
types of exit from work, including official early retire-
ment and unemployment.
Economic burden (INDIRECT COSTS)
In order to calculate the productivity loss (indirect
costs) of early exit from work attributable to OA in
Portugal’s mainland we adopted the society’s perspec-
tive, which considers the aggregate value of indirect
costs for all parts in the Society (including patients,
employers, and the government), and used the human
capital approach. This method estimates productivity
by valuing healthy time lost due to OA using market
wage rates, which can be viewed as the loss of an in-
vestment in a person’s human capital [27]. Early exit
from paid employment associated with OA was
assessed through logistic regression models. A good
measure of the impact of OA in the early exit from
work may be the population attributable fractions
(PAF), which take into account both the strength of
the association between OA and early exit from work,
as measured in the logistic regression models, and
the prevalence of OA in the population surveyed.
PAF were calculated as the resulting proportional
change in the probability of premature work with-
drawal following a counterfactual exercise in which
the presence of OA was artificially eliminated from
the sample. This recalculated probability of exit from
work was then used to estimate the indirect costs
attributable to OA by multiplying each observation’s
probability change with the corresponding unit value
of production. The unit values of production were
assessed by obtaining the market wage rates from na-
tional public sources [28]. These figures needed to be
grossed up by social security contributions. This ap-
proach yielded an annual average value of €24,891 for
men and €16,079 for women, for ages between 50
and 64. All unit values of production were stratified
by age, gender, and geographic region (Appendix 1).
Statistical analysis
Descriptive analysis was mainly performed by compar-
ing early withdrawals from work (including early re-
tirees) versus the employed participants of the sample
analysed. Prevalence of early exit from work and
other characteristics were computed as weighted data,
in order to take into account the stratified sampling
design of the survey. Missing values were not re-
placed and all statistics were calculated based on
non-missing values. To explore the association be-
tween OA and early exit from work we built multi-
variable logistic regression models by means of a
manual stepwise technique (backward elimination)
using the following potential confounders: age, gender,
region, marital status, education, household income,
BMI, and chronic diseases. Pain and disability were
not included in the multivariable models since they
are considered intermediate factors of OA within the
etiologic model adopted [29, 30]. Their association
with the outcome was instead analysed separately
adjusted for age, gender, and region. All statistical
analyses were carried out using Stata IC V.12 (Stata-
Corp, 2011. Stata Statistical Software: Release 12.
College Station, Texas, USA: StataCorp LP).
Results
Amongst the survey respondents, more than half of
the population aged between 50 and 64 years were
out of paid work (51.8%. Table 1) and had an OA
prevalence of about 30% (29.7%; men: 16.2% and
women: 43.5%. Knee OA: 18.6%; hand: 12.6%; hip: 3.
6%). Lower education and monthly household in-
come were more frequent in the premature with-
drawals, whilst the marital status single was more
likely found in the employed. The out-of-work group
had a poorer health status, with higher comorbidity
scores, lower quality of life, and lower functional
capacity. Higher prevalence of diabetes and neuro-
logical disorders were also found in this group. In
comparison to the paid employment group, OA
prevalence was significantly higher in all other
groups (Table 1).
The participants with OA had more comorbidities
(Comorbidity score: 2.3 vs 1.7; p < 0.001. Table 2), in
particular diabetes, gastrointestinal and mental dis-
orders, and were more likely to self-report other
main chronic diseases (age, gender, and region
adjusted OR: 1.70; CI: 1.07–2.69; p = 0.023). OA par-
ticipants had poorer quality of life measured by all
SF-36 items, especially the bodily pain index (54.9
vs. 72.6, p < 0.001), and by the EQ-5D score (0.68
vs. 0.83; p < 0.001). OA patients more frequently
reported longstanding musculoskeletal pain than
non-OA (52.5% vs. 34.1%; p < 0.001). The OA popu-
lation also scored worse in functional capacity mea-
sured by the HAQ scale (0.64 vs. 0.28; p < 0.001).
This is especially true for the knee OA location
(mean score: 0.61, 95%CI: 0.53–0.69). Within the
OA group, 61.8% were not working versus 47.6% for
those without OA (p = 0.004). Most were females
(71.0% versus 41.9% for those non-OA in the out-
of-work group; p < 0.001). A non-significant differ-
ence was observed when analysing early retirement
specifically (32.6% vs. 29.1%, respectively; p = 0.437.
Table 2). Unemployment is a major early route of
work loss in the OA population (17.7% vs. 9.9% for
non-OA; p = 0.002). The vast majority of registered
unemployment lasted more than 12 months (95.8%).
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Figure 1 shows how unemployment rates were high
amongst the youngest of the OA population (i.e. 50–56)
whilst being surpassed by official early retirement after
approximately the age of 56. A distinct dynamic is ob-
served in the non-OA population, in which unemploy-
ment rates are in line with early retirement below age 55.
Table 1 General description of the sample by employment status: EpiReumaPt ages 50–64 (n = 1286)
UNEMPLOYMENT EARLY RETIREMENT EXIT FROM WORK PAID EMPLOYMENT
Employment Status 12.2% 30.2% 51.8% 48.2%
Age (years) 55.2 (p = 0.192)* 59.9 (p < 0.001)* 58.2 (p < 0.001)* 54.6
Gender (female) 55.3% (p = 0.187) 44.2% (p = 0.757) 52.2% (p = 0.305) 46.3%
Marital Status
Single 11.7% 3.4% 5.7% 14.9%
Married/Consensual union 70.6% 77.3% 76.2% 64.5%
Divorced 14.3% 10.4% 10.3% 15.3%
Widowed 3.4% (p = 0.673) 8.9% (p = 0.002) 7.8% (p = 0.007) 5.2%
Body Mass Index
Underweight (< 18.5m2/kg) 0% 0.5% 0.5% 0.4%
Normal (18.5-25 m2/kg) 28.5% 25.7% 27.0% 30.5%
Overweight (25-30 m2/kg) 44.6% 50.3% 46.3% 46.7%
Obese (≥30m2/kg) 27.7% (p = 0.788) 23.5% (p = 0.801) 26.2% (p = 0.762) 22.4%
Clinically Confirmed OA 42.8% (p < 0.001) 32.1% (p = 0.08) 35.4% (p = 0.003) 23.5%
Knee OA 29.0% (p < 0.001) 22.0% (p = 0.005) 24.2% (p < 0.001) 12.6%
Hand OA 14.3% (p = 0.413) 12.3% (p = 0.797) 13.6% (p = 0.405) 11.6%
Hip OA 3.1% (p = 0.795) 4.2% (p = 0.809) 3.6% (p = 0.998) 3.6%
Chronic Diseases (self-reported)
Cardiovascular 60.6% (p = 0.740) 62.8% (p = 0.991) 63.7% (p = 0.874) 62.8%
Diabetes 10.1% (p = 0.180) 17.5% (p = 0.003) 15.9% (p < 0.001) 6.4%
Pulmonary 11.5% (p = 0.147) 7.5% (p = 0.407) 9.9% (p = 0.110) 5.0%
Allergy 22.4% (p = 0.411) 20.5% (p = 0.242) 22.4% (p = 0.356) 27.5%
Gastrointestinal 22.6% (p = 0.460) 26.6% (p = 0.114) 25.5% (p = 0.102) 19.1%
Neoplasic 5.9% (p = 0.458) 6.5% (p = 0.282) 5.7% (p = 0.338) 3.9%
Mental 15.8% (p = 0.493) 13.6% (p = 0.942) 17.2% (p = 0.130) 13.4%
Neurologic 1.6% (p = 0.644) 6.7% (p = 0.005) 4.8% (p = 0.004) 1.2%
Comorbidity Score 1.87 (p = 0.471) 2.03 (p = 0.10) 2.04 (p = 0.03) 1.74
Longstanding Musculoskeletal Pain 47.0% (p = 0.049) 39.7% (p = 0.399) 43.9% (p = 0.073) 34.8%
Functional Capacity - HAQ 0.48 (p = 0.012) 0.43 (p = 0.033) 0.47 (p = 0.002) 0.28
Quality of Life – EQ-5D 0.72 (p < 0.001) 0.79 (p = 0.152) 0.75 (p = 0.002) 0.83
Educational Level
Primary or less 55.0% 64.0% 63.4% 37.3%
Medium 23.3% 17.6% 19.6% 28.5%
High 21.7% (p = 0.024) 18.4% (p < 0.001) 17.0% (p < 0.001) 34.2%
Monthly Household Income
≤ €500 49.2% 22.3% 29.8% 12.1%
€501–€1000 36.3% 37.6% 40.7% 38.6%
€1001–€2000 8.5% 28.7% 20.7% 33.1%
> €2000 6.0% (p < 0.001) 11.4% (p = 0.243) 8.8% (p = 0.001) 16.2%
All results were computed as weighted proportions to keep in account the sampling design of the survey
*all p values versus paid employment. OA, Osteoarthritis; HAQ, Health Assessment Questionnaire; EQ-5D, European Quality of Life index
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Association between OA and early exit from work
OA is associated with early exit from work (OR: 1.85;
95%CI: 1.27–2.69; p = 0.001), but not with official early
retirement (OR: 1.43; 95%CI: 0.96–2.12; p = 0.08). Knee
location of OA is strongly associated with early exit from
work (OR: 2.25; 95%CI: 1.42–3.59; p = 0.001. Appendix
2), while no significant association was observed for
hand OA (OR: 1.17; 95%CI: 0.76–1.80; p = 0.477) or hip
OA (OR: 1.04; 95%CI: 0.36–2.99; p = 0.938). As men-
tioned above, unemployment seems to be a major chan-
nel of exit from work for patients with OA (OR: 1.97;
95%CI: 1.27–3.06; p = 0.002), especially for knee OA
Table 2 Description of the sample by OA diagnosis, including pain, functional status and quality of life results (SF-36 and EQ-5D):
EpiReumaPt ages 50–64 (n = 1286)
OA (n = 382) NON-OA (n = 904)
Age (years) 57.5 56.0 (p < 0.001)*
Gender (female) 72.3% 39.6% (p < 0.001)
Employment Status
Unemployment 17.7% 9.9% (p = 0.002)
Early Retirement 32.6% 29.1% (p = 0.437)
Exit from Work 61.8% 47.6% (p = 0.004)
Educational Level
Primary or less 57.9% 47.9%
Medium 20.2% 25.4%
High 21.8% 26.7% (p = 0.148)
Body Mass Index
Underweight (< 18.5m2/kg) 0.5% 0.4%
Normal (18.5-25 m2/kg) 26.9% 29.5%
Overweight (25-30 m2/kg) 42.3% 48.3%
Obese (≥30m2/kg) 30.3% 21.8% (p = 0.207)
Chronic Diseases (self-reported)
Cardiovascular 68.9% 61.0% (p = 0.108)
Diabetes 15.5% 9.5% (p = 0.027)
Pulmonary 7.7% 7.5% (p = 0.962)
Allergy 29.7% 22.8% (p = 0.158)
Gastrointestinal 32.0% 18.3% (p < 0.001)
Neoplasic 4.0% 5.2% (p = 0.454)
Mental 19.3% 13.8% (p = 0.029)
Neurologic 3.5% 2.9% (p = 0.602)
Comorbidity Score 2.3 1.7 (p < 0.001)
Longstanding Musculoskeletal Pain 52.5% 34.1% (p < 0.001)
SCORE HAQ (0–3 from best to worst) 0.64 0.28 (p < 0.001)
SCORE EQ-5D (0–100 from worst to best imaginable health state) 0.68 0.83 (p < 0.001)
SF-36 physical function (0–100 from worst to best) 65.2 80.8 (p < 0.001)
SF-36 role limitations because of physical health problems 59.8 77.3 (p < 0.001)
SF-36 bodily pain 54.9 72.6 (p < 0.001)
SF-36 social functioning 80.3 87.8 (p < 0.001)
SF-36 general mental health 58.8 69.7 (p < 0.001)
SF-36 role limitations because of emotional problems 71.2 85.3 (p < 0.001)
SF-36 vitality 51.4 61.9 (p < 0.001)
SF-36 general health perceptions 47.8 56.6 (p < 0.001)
All results were computed as weighted proportions to keep in account the sampling design of the survey
*All p values: OA versus non-OA. OA, Osteoarthritis; HAQ, Health Assessment Questionnaire; EQ-5D, European Quality of Life index; SF-36, Short-Form Health Survey
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(OR: 2.68; 95%CI: 1.58–4.53; p < 0.001. Table 2), and for
the youngest (50–57) from the sample (OR: 3.47; 95%CI:
1.88–6.41; p < 0.001).
Pain and disability
Pain plays a key role in the risk of workforce with-
drawal. A strong association was seen between pain
interference and premature work loss, especially
within the knee OA population (OR: 1.52; 95%CI: 1.
16–1.99; p = 0.002). Those who scored worse in pain
interference were more often out-of-work (Fig. 2). In
fact, not only was the OA population more likely to
score worse (p = 0.02) in this parameter, but also the
aforementioned association between knee OA and exit
from work becomes non-significant if only the subset
of population with low pain interference is analysed
(i.e. “not at all” “to a little bit” pain interference. OR:
1.52; 95%CI: 0.95–2.44; p = 0.08).
Furthermore, knee OA patients with the highest
levels of disability measured by HAQ (scores ≥2), are
at the greatest risk of early exit from work (80.7% vs.
67.4% for all knee OA population and 51.2% for those
with HAQ scores ≥2 but without knee OA). We esti-
mated an almost linear relationship between levels of
Fig. 1 Prevalence of Early Exit from Work, Early Retirement and Unemployment according to ages 50–64 (n = 1286). All results were computed as
weighted proportions to keep in account the sampling design of the survey. OA, Osteoarthritis
Fig. 2 Pain Affecting Work and Domestic Activities & Early Exit from Work (n = 1286). All results were computed as weighted proportions to
keep in account the sampling design of the survey. Lines indicate Early Exit from Work (all p-values of Knee OA versus No Knee OA groups are
non-significant). Bars indicate Pain Interference distribution by intensity levels (p = 0.02) with corresponding 95% confidence intervals
(vertical lines). OA, Osteoarthritis
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disability and the probability of early exit from paid
employment, with its y-intercept increasing with the
presence of knee OA (Appendix 3). Similarly to what
was observed with pain, the association between knee
OA and exit from work becomes non-significant if
only the subset of population with less disability is
analysed (i.e. HAQ scores below the average of the
population [0.38]. OR: 0.74; CI: 0.28–1.99; p = 0.552).
Economic burden
The estimated annual indirect cost due to premature
exit from work attributable to OA was €656 million
(€384 per capita; €1294 per OA patient and €2095
per OA patient out-of-work). Females contributed
with 61.6% of these costs (€404 million), but mean
per capita indirect costs were greater for OA males
(cost per OA male patient: €1795 vs. €1102 for fe-
males; cost per OA male patient out-of-work: €2776
vs. €1817 for females Fig. 3).
Discussion
In this study, using the first nationwide epidemio-
logical population-based survey that evaluated rheum-
atic diseases in Portugal, we found an association
between clinically confirmed OA and early exit from
paid employment. However, this relationship was only
found for the knee OA (not for hip or hand OA). We
also estimated that OA might have led to annual
indirect costs amounting to approximately 0.4% of the
2013 national Gross Domestic Product (GDP).
Women contributed with 61.6% of this productivity
loss, whilst OA men have higher mean per capita
indirect costs given the higher average unit values of
production associated with male gender [31].
As expected [1], OA patients are mostly ageing
females when compared with the non-OA population.
They have lower levels of education, lower household in-
come, poorer self-reported quality of life, and a higher
number of comorbidities. These characteristics may
themselves influence labour force participation. In fact,
we observed an association between premature work
loss and lower levels of education, marital status (mar-
ried or widowed), neurological diseases, and lower
household income. Nevertheless, the association we
found between clinically confirmed OA and premature
work withdrawal is robust and independent of other in-
fluencing factors, which is consistent with previously
published data [32–34].
OA generates disabling pain, which might push
patients to leave work prematurely [14]. We captured
pain through alternative measures (i.e. pain interference,
bodily pain item from the SF-36 questionnaire, and self-
reported longstanding musculoskeletal pain) and, as
expected, OA patients consistently report more pain
than others without the condition. In addition, we ob-
served a relation between pain and withdrawal from
employment. This is consistent with the literature
[32, 35, 36]. For instance, Dibonaventura et al., using
data from the US National Health and Wellness Survey,
have shown that individuals with OA pain were less likely
to be employed relative to workers without OA pain [35].
We also detected that OA patients with higher levels of
disability, measured by high scores of HAQ, were at the
highest risk of early exit from work. This also aligns with
earlier research [37, 38] and with the etiological model
adopted, which assumes that OA generates pain, impair-
ment, and disability that may ultimately lead to work with-
drawal. Thus, we confirmed in our research and study
population that pain and disability are key factors for job
loss driven by OA.
Interestingly, we did not find a statistical association
between OA and official early retirement (regardless
of anatomic location). OA seems instead to drive the
labour force out of paid employment mainly through
unemployment. This is particularly evident in the
earlier ages. Thereafter unemployment is overtaken by
early retirement when patients with OA get closer to
the official retirement age. We did not find the same
interplay between age-specific frequencies of retire-
ment and unemployment in the non-OA population.
Thus, unemployment appears to be the predominant
first step to irreversible out-of-work state in OA pa-
tients, although likely not being fully converted into
official early retirement, given the lack of association
between early retirement and OA (in Portugal, under
some circumstances, unemployment benefits may be
converted into the old-age pension before reaching
the statutory retirement age).
It would be valuable to further explore if this oc-
curs because labour market policies are restricting
early retirement in this sort of patients (e.g. formal
rejection of early retirement applications to Social
Fig. 3 Indirect costs per capita in the Portuguese population aged
50–64, per OA patient and per OA patient out of work (n = 1286).
OA, Osteoarthritis
Laires et al. BMC Public Health  (2018) 18:472 Page 7 of 12
Security from employees with OA) or if other reasons
are taking the lead instead. This finding highlights the
need to target research and integration-oriented pol-
icies toward unemployment generated by OA. More
knowledge in this area may produce employment
gains since premature retirement restriction policies
by themselves are insufficient to mitigate the job
losses, as alternative routes may take place as seen
herein in the OA case. Although unemployment ben-
efits may be time limited, from the societal perspec-
tive these pathways of early exit from work embody
the same economic burden (i.e. identical productivity
losses), and therefore strategies that simply push indi-
viduals from one route to another are truly not
socially efficient.
In this nationwide study, we estimated a substantial
economic burden following early exit from work attrib-
utable to OA, equivalent to an indirect annual cost of
€656 million euros (€2061 per patient). Earlier re-
search in other countries has measured different
yearly indirect costs of OA per patient [39–46]. Com-
paring results of cost-of-illness studies is hampered by
discrepancies across study designs, case definition,
methodological choices, wage levels, and sources of
data used [47]. Additionally, these cost results vary
with time and geography. However, there are some
common take-away messages: First, the economic
burden of osteoarthritis is considerable and closely re-
lated to its high prevalence. Second, indirect costs are
likely to surpass other per patient costs (e.g. drug and
other medical costs) [42, 48, 49]. Third, these costs
are also likely to exceed those from other chronic dis-
abling conditions. For example, Schofield et al. mea-
sured annual losses of arthritis through early
retirement (approximately 0.7% of GDP) [50] superior
to other pathologies, such as cardiovascular disease
[51], diabetes [52], and mental disorders [53].
This study has several limitations that must be
taken into account when interpreting its results. First,
it may be limited by the cross-sectional design, which
does not allow for an evaluation of the temporal rela-
tionship between onset of OA and time of exit from
paid employment, which would help in establishing a
cause–effect relationship. Lack of available national
longitudinal data made this limitation impossible to
overcome. Nevertheless, onset of OA is likely to start
before premature exit from paid employment and
reverse causality is unlikely (i.e. early exit from work
as a risk factor to OA onset). Second, wages were
estimated through official statistics based on gender,
region, and age. Necessarily, this methodology is a
rough estimate of the individual unit values of pro-
duction. In particular, OA patients are likely associ-
ated with lower incomes. Still, given the information
available, it is the best feasible method. Third, due to
the cross-sectional design, our results are right-
censored, leading to likely underestimation of the re-
sults (i.e. further exit from work is more probable to
occur than return to work within the sample until all
participants reach the official retirement age). Finally,
not all potential hidden confounding factors could be
addressed. However, we do not consider our analysis
to be overly influenced by this limitation given the
richness of the EpiReumaPt dataset and the large
number of control variables thus afforded.
This study has several strengths as well. It is based on
the largest population-based study about rheumatic
diseases ever performed in Portugal (i.e. high external
validity). It uses confirmed diagnosis of OA done by
rheumatologists (i.e. very strict and controlled case
definition). To our knowledge, this must be amongst the
few studies focusing on indirect costs of OA based on
such a representative sample specifically dedicated to
rheumatic and musculoskeletal conditions, a sample that
is likely to accurately reflect this particular type of eco-
nomic impact on society. It will certainly facilitate future
research on the cost-effectiveness of interventions
targeting reduced work ability due to OA.
Unquestionably, this issue deserves further atten-
tion. Recently, access to early retirement was re-
stricted in some European countries that are still
lacking in integration policies such as vocational
rehabilitation programmes [54]. Since OA is highly
disabling and prevalent, especially at ages near the
statutory retirement age, it might well be an ideal
area in which public policies might strive for a better
balance between restricting early retirement and inte-
gration policies. Moreover, OA is a musculoskeletal
disease for which the etiological model (from the
onset of symptoms/pain until work withdrawal) may
be further understood and subsequently disrupted by
effective health interventions.
Conclusions
This population-based study unveils the impact of
the association between OA and early exit from paid
employment. It describes the high economic burden
underlying this association. The findings justify giv-
ing more attention to OA when discussing policies
facing the ageing of higher income countries. The
depreciation in the stock of human capital due to
OA is already extensive, and given the demographic
and epidemiological trends, it may even worsen if
nothing is done. This research should provide im-
portant evidence for decision makers to prioritize in-
vestments in health and policies targeting patients
with OA.
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Table 3 Summary of average unit values of production by gender, age and geographic region (2013)
Age National North Center Lisbon Alentejo Algarve
MEN
50 €22,868 €21,271 €21,091 €32,376 €21,147 €19,808
51 €23,875 €21,066 €20,753 €32,081 €21,659 €18,518
52 €24,609 €21,357 €20,290 €31,991 €22,772 €19,523
53 €24,688 €21,497 €20,834 €32,895 €22,182 €18,722
54 €25,831 €21,942 €20,475 €31,422 €24,079 €19,314
55 €25,624 €22,005 €21,086 €32,877 €23,712 €20,063
56 €25,185 €22,005 €21,065 €33,006 €24,686 €18,943
57 €25,813 €22,665 €20,187 €33,248 €23,917 €20,398
58 €23,696 €22,757 €20,719 €34,349 €24,228 €18,808
59 €25,881 €23,593 €21,222 €34,765 €25,096 €20,406
60 €23,843 €21,586 €20,037 €32,585 €24,078 €19,509
61 €26,350 €22,616 €21,393 €36,334 €22,330 €19,943
62 €25,966 €24,180 €20,432 €34,934 €25,275 €18,210
63 €24,645 €23,053 €19,851 €33,056 €25,360 €17,408
64 €24,490 €24,474 €20,181 €34,764 €28,163 €17,266
Average (50–64) €24,891 €22,404 €20,641 €33,379 €23,912 €19,123
WOMEN
50 €16,290 €14,524 €13,384 €20,811 €13,740 €15,466
51 €15,880 €14,864 €13,451 €20,522 €13,811 €15,637
52 €16,709 €15,202 €13,291 €20,965 €14,281 €15,595
53 €16,165 €15,006 €13,067 €21,020 €14,068 €14,931
54 €17,526 €15,250 €13,158 €21,075 €13,612 €14,653
55 €16,504 €15,379 €13,459 €20,312 €13,731 €15,434
56 €15,437 €15,251 €13,343 €21,297 €14,298 €15,507
57 €15,557 €15,313 €12,612 €20,181 €14,629 €15,402
58 €15,359 €15,205 €13,018 €19,968 €13,632 €14,444
59 €16,881 €16,023 €14,525 €19,495 €13,140 €15,262
60 €15,727 €15,726 €13,192 €19,362 €13,180 €15,151
61 €16,103 €15,792 €12,819 €19,901 €13,359 €13,546
62 €15,954 €15,860 €13,088 €20,745 €13,340 €14,257
63 €15,629 €15,452 €13,850 €18,797 €13,298 €16,413
64 €15,460 €15,489 €13,070 €17,956 €13,426 €14,059
Average (50–64) €16,079 €15,356 €13,288 €20,160 €13,703 €15,050
NATIONAL €20,255
Note: National values are weighted averages according with each age, sex and region population size
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Table 4 Logistic regression analysis by type of early exit from paid employment
Unemployment Early Retirement Early Exit From Paid Employment
Univariable OR
(95% CI)
Multivariable OR
(95% CI)a
Univariable OR
(95% CI)
Multivariable OR
(95% CI)a
Univariable OR
(95% CI)
Multivariable OR
(95% CI)a
Knee Osteoarthritis 1.97* (1.25–3.10) 2.68* (1.58–4.53) 1.37 (0.90–2.08) – 2.22* (1.49–3.29) 2.25* (1.42–3.59)
Age 0.99* (0.97–1.00) 0.98* (0.97–1.00) 1.03* (1.01–1.04) 1.03* (1.01–1.04) 1.01 (1.00–1.03) 1.01* (1.00–1.03)
Gender (Female) 1.31 (0.83–2.09) 1.06 (0.61–1.84) 0.75 (0.47–1.18) 0.64 (0.41–1.00) 1.27 (0.80–2.00) 1.23 (0.79–1.93)
Educational level (Ref: Primary or less)
Medium 0.89 (0.51–1.56) – 0.47* (0.26–0.84) 0.46* (0.23–0.92) 0.41* (0.22–0.74) 0.31* (0.18–0.55)
High 0.77 (0.44–1.34) – 0.46* (0.26–0.80) 0.62 (0.36–1.06) 0.29* (0.17–0.49) 0.49* (0.27–0.89)
Marital Status (Ref: Single)
Married/Consensual Union 0.85 (0.36–1.99) – 4.38* (1.81–10.57) 4.21* (1.62–10.92) 3.11* (1.30–7.43) 5.28* (2.24–12.45)
Divorced 0.97 (0.36–2.57) – 2.89 (0.97–8.63) 2.99 (0.97–9.22) 1.77 (0.64–4.87) 1.78 (0.69–4.58)
Widowed 0.41 (0.13–1.29) – 6.14* (2.23–16.93) 6.08* (2.00–18.48) 3.93* (1.50–10.29) 4.04* (1.34–12.17)
Chronic Diseases
Cardiovascular 0.88 (0.55–1.42) – 0.97 (0.58–1.62) – 1.04 (0.64–1.68) –
Diabetes 0.87 (0.47–1.61) 2.25* (1.30–3.89) 1.92* (1.09–3.41) 2.78* (1.67–4.65) –
Pulmonary 0.98 (0.43–2.24) – 2.08 (0.83–5.21) – 2.08 (0.84–5.15) –
Allergy 0.86 (0.51–1.44) – 0.70 (0.41–1.20) – 0.76 (0.43–1.33) –
Gastrointestinal 1.02 (0.63–1.66) – 1.40 (0.89–2.23) – 1.45 (0.91–2.31) –
Neoplasic 1.27 (0.50–3.26) – 1.61 (0.70–3.70) – 1.51* (0.62–3.65)
Mental 1.04 (0.64–1.70) – 0.82 (0.54–1.23) – 1.34 (0.91–1.99) –
Neurologic 0.50 (0.15–1.59) – 4.83* (2.19–10.66) 5.00* (1.95–12.83) 4.17* (1.83–9.50) 4.58* (1.40–15.00)
Household Income (Ref: ≤€500)
>€500 and≤ €1000 0.31* (0.18–0.55) 0.36* (0.20–0.64) 0.84 (0.43–1.62) – 0.43* (0.23–0.80) 0.40* (0.23–0.69)
>€1000 and≤ €2000 0.10* (0.04–0.24) 0.12* (0.05–0.28) 0.98 (0.45–2.12) – 0.26* (0.12–0.54) 0.25* (0.12–0.53)
>€2000 0.15* (0.06–0.43) 0.18* (0.06–0.50) 0.79 (0.34–1.81) – 0.22* (0.10–0.49) 0.25* (0.10–0.65)
Regional Controls YES YES YES
OR odds ratio, CI confidence interval, *p < 0.05
a - All multivariable models were adjusted for age, gender, geographic region (7 main regions: North, Center, Lisbon region, Alentejo, Algarve, Azores and Madeira),
marital status, education level, household income, body mass index and chronic diseases. Cofactors were excluded in the stepwise method if p > 0.05 (except for age
and gender)
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